T-Stat
Generic name:erythromycin
Dosage form: Topical Solution
Drug classes:Topical acne agents, Topical antibiotics
Medically reviewed by Drugs.com. Last updated on Apr 21, 2022.
For topical use only. Not for ophthalmic use.
On This Page
The T-Stat brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
T-Stat Description
Erythromycin is an antibiotic produced from a strain of Streptomyces erythraeus. It is basic and readily forms salts with acids. Each ml of T-Stat (erythromycin) 2.0% Topical Solution contains 20 mg of erythromycin base in a vehicle consisting of alcohol (71.2%), propylene glycol and fragrance. It may contain citric acid to adjust pH.
ACTIONS
Although the mechanism by which T-Stat Solution acts in reducing inflammatory lesions of acne vulgaris is unknown, it is presumably due to its antibiotic action.
INDICATIONS
T-Stat Solution is indicated for the topical control of acne vulgaris.
Contraindications
T-Stat Solution is contraindicated in persons who have shown hypersensitivity to any of its ingredients.
Warning
The safe use of T-Stat (erythromycin) 2.0% Solution during pregnancy or lactation has not been established.
Precautions
General
The use of antibiotic agents may be associated with the overgrowth of antibiotic-resistant organisms. If this occurs, administration of this drug should be discontinued and appropriate measures taken.
Information for Patients
T-Stat Solution is for external use only and should be kept away from the eyes, nose, mouth, and other mucous membranes. Concomitant topical acne therapy should be used with caution because a cumulative irritant effect may occur, especially with the use of peeling, desquamating, or abrasive agents.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term animal studies to evaluate carcinogenic potential, mutagenicity, or the effect on fertility of erythromycin have not been performed.
Pregnancy: Pregnancy Category C
Animal reproduction studi...